Pharma Deals Review, Vol 2008, No 98 (2008)

Font Size:  Small  Medium  Large

Shire Acquisition Provides Company with a Market-Ready Drug

Sally Mardikian PhD

Abstract


Shire adds yet another rare disease-targeting drug to its portfolio with its acquisition of Berlin-based Jerini.

Full Text: pdf html

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.